Inovio Pharmaceuticals
INO
INO
126 hedge funds and large institutions have $135M invested in Inovio Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 37 increasing their positions, 27 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
1% less funds holding
Funds holding: 127 → 126 (-1)
6% less call options, than puts
Call options by funds: $299K | Put options by funds: $318K
21% less capital invested
Capital invested by funds: $171M → $135M (-$36.2M)
Holders
126
Holding in Top 10
1
Calls
$299K
Puts
$318K
Top Buyers
| 1 | +$4.98M | |
| 2 | +$4.77M | |
| 3 | +$3.01M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$2.61M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$1.33M |
Top Sellers
| 1 | -$7.2M | |
| 2 | -$2.64M | |
| 3 | -$2.16M | |
| 4 |
D.E. Shaw & Co
New York
|
-$1.94M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.48M |